New study tests alternative to prevent bone loss after stopping popular osteoporosis drug
NCT ID NCT07406685
Summary
This study aims to find out if a drug called ibandronate works as well as the current standard drug, zoledronic acid, to protect bones after women stop taking denosumab for osteoporosis. It will involve 52 postmenopausal women who have taken denosumab for less than three years. Researchers will measure changes in bone density and strength over two years to see which treatment better prevents bone loss and fractures.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOPOROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
National Taiwan University Hospital
Taipei, 100, Taiwan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.